Cardiovascular 2 Anti-hypertensives Flashcards
Drug class for Propranolol
sympatholytics: peripheral adrenergic ‘r’ blockers-beta blockers
MoA for Propranolol
adrenergic B1 & B2 receptor inhibitor: reduction in myocardial oxygen demand
Indications for Propranolol
angina, HTN, tachyarrhythmias, essential tremor, migraine Px, anxiety
SE/ADRs for Propranolol
fatigue, sleep disturbance, depression
Contra-indications for Propranolol
hypersensitivity, bradycardia, heart block, uncompensated HF, severe depression, bronchospasm
Dx-Dx interactions for Propranolol
ethanol (may increase or decrease conc)
Monitoring for Propranolol
BP, chest pain, HR, LFTs
What might Propranolol mask?
hypoglycemia
Drug class for Metoprolol
sympatholytics: peripheral adrenergic ‘r’ blocker-beta blocker
MoA for Metoprolol
selective B1 adrenergic receptor inhibitor
Indications for Metoprolol
angina, HTN, hemodynamically stable post MI
SE/ADRs for Metoprolol
fatigue, sleep disturbance, depression, bradycardia, rebound angina/HTN, hypotension
Contra-indications for Metoprolol
hypersensitivity, bradycardia, heart block, uncompensated heart failure, severe depression
Dx-Dx interactions for Metoprolol
multiple
Monitoring for Metoprolol
BP, HR, LFTs
Drug class for Atenolol
sympatholytics: peripheral adrenergic ‘r’ blockers-beta blockers
MoA for Atenolol
selective B1 adrenergic receptor inhibitor
Indications for Atenolol
angina, HTN, hemodynamically stable post MI
SE/ADRs for Atenolol
fatigue, sleep disturbance, depression, bradycardia, rebound angina, HTN, hypotension
Contra-indications for Atenolol
hypersensitivity bradycardia, heart block, uncompensated heart failure, severe depression
Dx-Dx interactions for Atenolol
multiple
Monitoring for Atenolol
BP, HR, eGFR
Drug class for Prazosin
alpha-blocker
MoA for Prazosin
selective alpha1 blocker which relaxes smooth muscle in arteries, veins, & prostate
Indications for Prazosin
HTN, off-label: PTSD, Raynaud’s phenomenon
SE/ADRs for Prazosin
postural hypotension, nausea, drowsiness, syncope, palpitations, dizziness, ‘floppy iris’ syndrome
Contra-indications for Prazosin
orthostatic hypotension
Dx-Dx interactions for Prazosin
PDE-5 blockers (Tadalafil), anti-hypertensive meds
Monitoring for Prazosin
BP, BUN, eGFR, syncopal episodes
PG category for Prazosin
C but avoid
Drug class for Carvedilol
B1, B2, A1 blockers
MoA for Carvedilol
mixed alpha, beta receptor inhibitor
Indications for Carvedilol
angina (off label), HTN, stable HF, stable post MI
SE/ADRs for Carvedilol
fatigue, sleep disturbance, depression, bradycardia, rebound angina/HTN, hypotension
Contra-indications for Carvedilol
hypersensitivity, bradycardia, heart block, uncompensated HF, severe depression, bronchospasm, severe liver failure
Dx-Dx interactions for Carvedilol
multiple
Monitoring for Carvedilol
BP, HR, eGFR, LFTs
Drug class for Clonidine
centrally acting A2 agonist
MoA for Clonidine
stimulates A2 receptors in brain stem which stimulates inhibitory neuron resulting in reduced sympathetic outflow from CNS which results in reduction in TPR
Indications for Clonidine
HTN (immediate release form), ADHD (extended release form), Narcotic addiction
SE/ADRs for Clonidine
bradycardia, drowsiness, HA, rash, xerostomia, weakness
Contra-indications for Clonidine
pre-existing CNS depression, severe CAD, caution in CKD, recent AMI, stroke
Dx-Dx interactions for Clonidine
meds altering AV/SA nodal function, ethanol
Monitoring for Clonidine
BP, mental status, HR
PG category for Clonidine
C but avoid
Drug class for Methyldopa
centrally acting A2 agonist
MoA for Methyldopa
central alpha-adrenergic inhibition decrease sympathetic outflow to heart, kidneys, peripheral vasculature
Indications for Methyldopa
HTN in PG
SE/ADRs for Methyldopa
depression, anxiety, dry mouth, hemolytic anemia, liver disease, edema
Contra-indications for Methyldopa
hepatic disease
Dx-Dx interactions for Methyldopa
MAO inhibitors
Monitoring for Methyldopa
LFT, CrCl, BP, eGFR
Drug class for Captopril, Lisinopril, Fosinopril
renin-angiotensin inhibitors: ACEI
MoA for Captopril, Lisinopril, Fosinopril
competitive inhibitor of ACE preventing conversion of A1 to A2, decreasing vasoconstriction by A2 & decreases aldosterone secretion